Created: 2023-09-04
Updated: 2024-01-21
Company - BioOrbit
Product/Service
- Classification
- In-Space Manufacturing
- Category
- In-Space Manufacturing
- Fields
- Medicine and Drugs
Pharmaceutical
- Status
- Development
- First launch
- Not announced
BioOrbit is investigating the potential to manufacture cancer drugs in space, 2023-11-07.
- A start-up is developing technology to build a pharmaceuticals factory in space that could help improve the lives of patients undergoing antibody treatments for cancer and other diseases.
- Manufacture antibody cancer therapy drugs in space. These drugs would be administered from the home just as with insulin, which is itself composed of small crystals.
- A new approach, based on the crystallisation of drugs. If drugs are crystallised, they can be injected just under the skin, just as with insulin, which is itself, tiny crystals of insulin. However, protein antibody drugs are especially hard to crystallise, and when this is done on earth, they are not high enough quality.
- This is where space comes in. When antibodies are crystallised in space, in the absence of earth’s gravity, this allows for the creation of superior quality crystals compared to those formed on earth.